SCHEMBL4382436

SCHEMBL4382436

CCc1oc(-c2cccc(C(F)(F)F)c2)nc1CI.CCc1oc(-c2cccc(C(F)(F)F)c2)nc1COC[C@@H]1CCC[C@H](COC(C)(C)C(=O)O)C1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 11/20 0.39
PPARG P37231 9/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC16A3 O15427 4/20 0.37
SLC16A1 P53985 4/20 0.37
PPARD Q03181 3/20 0.37
MCTS1 Q9ULC4 2/20 0.37
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
KDM4E B2RXH2 1/20 0.33
UTRN P46939 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478526 0.96 PPARA (0.41) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4373453 0.96 PPARA (0.41) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL3975889 0.92 PPARG (0.37) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4384388 0.90 PPARG (0.38) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL1928298 0.88 PPARA (0.40) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4482451 0.87 PPARG (0.40) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4373520 0.87 PPARG (0.40) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4382433 0.87 PPARG (0.40) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL5484164 0.87 PPARG (0.40) PPARAPPARGALDH1A1MEN1KMT2A
SCHEMBL4478661 0.87 PPARG (0.40) PPARAPPARGALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1789402-B1 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES SANOFI AVENTIS DEUTSCHLAND (DE) 2009-11-18 EP disclosed
EP-1789402-A1 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES Sanofi-Aventis Deutschland GmbH (DE) 2007-05-30 EP disclosed
WO-2006018118-A1 2 - {-3-`2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-02-23 WO disclosed